HAP Trading’s Takeda Pharmaceutical TAK Stock Holding History

HAP Trading’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,000	Closed	-$27K	–	2743
2021 Q4	$27K	Sell	11,000 -380,200	-97%	-$5.33M	﹤0.01%	1709
2021 Q3	$559K	Buy	391,200 +1,500	+0.4%	+$25.2K	0.02%	644
2021 Q2	$647K	Buy	+389,700	New	+$6.63M	0.02%	577
2021 Q1	–	Sell	-529,900	Closed	-$124K	–	2330
2020 Q4	$124K	Buy	+529,900	New	+$9.3M	﹤0.01%	1102
2020 Q3	–	Sell	-531,700	Closed	-$862K	–	1865
2020 Q2	$862K	Buy	+531,700	New	+$9.55M	0.05%	302
2019 Q4	–	Sell	-519,900	Closed	-$1.27M	–	1465
2019 Q3	$1.27M	Sell	519,900 -1,106	-0.2%	-$19.1K	0.1%	170
2019 Q2	$1.37M	Buy	521,006 +13,300	+3%	+$242K	0.11%	151
2019 Q1	$4K	Buy	+507,706	New	+$10.2M	﹤0.01%	1029

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

HAP Trading's TAK Position: Q4 2023 in Review

HAP Trading sold out of Takeda Pharmaceutical (TAK) in Q4 2023, closing a stake of 263,679 shares — an estimated $4.08M sold.

HAP Trading first reported a position in TAK in Q2 2021 and held it in 6 quarters. The position peaked at $10.8M in Q4 2021. 306 funds tracked by Wall St. Rank hold TAK as of Q4 2023.

HAP Trading reported no remaining Takeda Pharmaceutical position as of Q4 2023 after selling out during the quarter.
HAP Trading sold 263,679 Takeda Pharmaceutical shares in Q4 2023, an estimated $4.08M.
HAP Trading first reported a position in Takeda Pharmaceutical in Q2 2021 and held it in 6 quarters.
HAP Trading's Takeda Pharmaceutical position peaked at $10.8M in Q4 2021.
306 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2023.

Based on HAP Trading's 13F filing for Q4 2023, filed 14 Feb 2024.